ICM
JBSS icon

Invenomic Capital Management’s John B. Sanfilippo & Son JBSS Stock Holding History

Invenomic Capital Management’s Portfolio JBSS Stock Details JBSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-73,886
Closed -$5.86M – 134
2026
Q1 		$5.86M Sell
73,886
-3,588
-5% -$276K 0.27% 96
2025
Q4 		$5.47M Buy
77,474
+47,864
+162% +$3.25M 0.25% 106
2025
Q3 		$1.9M Buy
+29,610
New +$1.92M 0.09% 135

Other funds holding JBSS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return

Invenomic Capital Management's JBSS Position: Q2 2026 in Review

Invenomic Capital Management sold out of John B. Sanfilippo & Son (JBSS) in Q2 2026, closing a stake of 73,886 shares — an estimated $5.86M sold.

Invenomic Capital Management first reported a position in JBSS in Q3 2025 and held it in 3 quarters. The position peaked at $5.86M in Q1 2026. 211 funds tracked by Wall St. Rank hold JBSS as of Q2 2026.

  • Invenomic Capital Management reported no remaining John B. Sanfilippo & Son position as of Q2 2026 after selling out during the quarter.
  • Invenomic Capital Management sold 73,886 John B. Sanfilippo & Son shares in Q2 2026, an estimated $5.86M.
  • Invenomic Capital Management first reported a position in John B. Sanfilippo & Son in Q3 2025 and held it in 3 quarters.
  • Invenomic Capital Management's John B. Sanfilippo & Son position peaked at $5.86M in Q1 2026.
  • 211 funds tracked by Wall St. Rank held John B. Sanfilippo & Son as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.